Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clobetasol vs Fractionated CO2 Laser for Lichen Sclerosus
NCT02573883Phase 3Completed
- Sponsor
- MedStar Health Research Institute
- Start
- Oct 2015
- Primary completion
- Sep 2019
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in vulvar lichen sclerosus (LS) (2 arms), sponsored by MedStar Health Research Institute. Primary endpoint: Skindex-29 Score at 6 months. Started Oct 2015; status: completed.
02
Conditions
vulvar lichen sclerosus (LS)
Beyond the preview
Go deeper on NCT02573883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02573883.